Pfizer Rid Mousse Pediculicide Approved Under "NDA Deviation"
This article was originally published in The Rose Sheet
Executive Summary
FDA approved an "NDA Deviation" (21-043) for Pfizer's Maximum Strength Rid Mousse aerosolized foam lice treatment March 7.